- Home
- FHN vs PCVX Comparison
FHN vs PCVX Comparison
Compare FHN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FHN | PCVX |
|---|---|---|
| Founded | 1864 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 6.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FHN | PCVX |
|---|---|---|
| Price | $24.56 | $47.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 7 |
| Target Price | $24.61 | ★ $101.67 |
| AVG Volume (30 Days) | ★ 5.7M | 1.5M |
| Earning Date | 01-15-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | ★ 20.88 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $3,184,000,000.00 | N/A |
| Revenue This Year | $12.70 | N/A |
| Revenue Next Year | $2.54 | N/A |
| P/E Ratio | $14.76 | ★ N/A |
| Revenue Growth | ★ 3.68 | N/A |
| 52 Week Low | $15.19 | $27.66 |
| 52 Week High | $24.44 | $93.77 |
Technical Indicators
Market Signals| Indicator | FHN | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 74.18 | 59.34 |
| Support Level | $23.54 | $42.40 |
| Resistance Level | $24.10 | $45.15 |
| Average True Range (ATR) | 0.46 | 1.94 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 94.86 | 91.70 |
Price Performance
Historical ComparisonAbout FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.